Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

• Status: Recruiting
• Trial end date: 2023-11-01

Summary

This study is designed to evaluate the efficacy and safety of adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) with raltitrexed or oxaliplatin versus no HIPEC in locally advanced colorectal cancer

• Phase: Phase 3

Details

• Lead Sponsor: Fudan University
• Treatments: Calcium; Calcium, Dietary; Capecitabine; Fluorouracil; Leucovorin; Levoleucovorin; Oxaliplatin; Raltitrexed